| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5344 | 2021 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1672 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1343 | 2021 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 675 | 2021 |
| Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 494 | 2021 |
| Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays KR Bewley, NS Coombes, L Gagnon, L McInroy, N Baker, I Shaik, ... Nature Protocols 16 (6), 3114-3140, 2021 | 239 | 2021 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity KA Ryan, KR Bewley, SA Fotheringham, GS Slack, P Brown, Y Hall, ... Nature communications 12 (1), 1-13, 2021 | 163 | 2021 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases, 2022 | 137 | 2022 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature communications 12 (1), 1-14, 2021 | 124 | 2021 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge KA Ryan, KR Bewley, SA Fotheringham, P Brown, Y Hall, AC Marriott, ... BioRxiv, 2020 | 42 | 2020 |
| Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD KJ Staples, S Taylor, S Thomas, S Leung, K Cox, TG Pascal, K Ostridge, ... PLoS One 11 (11), e0167250, 2016 | 41 | 2016 |
| mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P. 1 Brazilian variant H Parry, G Tut, R Bruton, S Faustini, C Stephens, P Saunders, C Bentley, ... Elife 10, e69375, 2021 | 24 | 2021 |
| BNT162b2 vaccination in people over 80 years of age induces strong humoral immune responses with cross neutralisation of P. 1 Brazilian variant HM Parry, G Tut, S Faustini, C Stephens, P Saunders, C Bentley, ... | 22 | 2021 |
| ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models T Lambe, AJ Spencer, KM Thomas, KE Gooch, S Thomas, AD White, ... Communications biology 4 (1), 1-12, 2021 | 20 | 2021 |
| Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques KR Bewley, K Gooch, KM Thomas, S Longet, N Wiblin, L Hunter, K Chan, ... Science advances 7 (37), eabg7996, 2021 | 19 | 2021 |
| Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma F Alexander, E Brunt, H Humphries, B Cavell, S Leung, L Allen, ... Bacterial Vaccines, 341-362, 2022 | 9 | 2022 |
| Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... bioRxiv, 2020 | 6 | 2020 |
| Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae SR Thomas, S Leung, K Knox, T Wilkinson, KJ Staples, P Lestrate, ... BMC microbiology 18 (1), 1-11, 2018 | 6 | 2018 |
| Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques KR Bewley, K Gooch, KM Thomas, S Longet, N Wiblin, L Hunter, K Chan, ... bioRxiv, 2020 | 5 | 2020 |
| Mutational signatures in countries affected by SARS-CoV-2: Implications in host-pathogen interactome (preprint) SA Rahman, J Singh, H Singh, A Basu, M Gack, S Tay, PO Craig, ... | | 2020 |
